Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

Leading the Way at ESC 2024

Press Releases | August 5, 2024 | Medscape Education

Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...

Driving equitable healthcare: The role of DE&I in clinical trials

White Papers and Resources | August 5, 2024 | Cuttsy + Cuttsy

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

Uniting Communities for Rare Disease Clinical Trial Success

Videos and Podcasts | August 2, 2024 | Innovative Trials

Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into...

Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

Videos and Podcasts | August 2, 2024 | Innovative Trials

In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to...

Solving your biggest patient recruitment and retention challenges

Videos and Podcasts | August 2, 2024 | Innovative Trials

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to...

Innovative Trials Announces New Charity Partnerships

Press Releases | August 2, 2024 | Innovative Trials

Innovative Trials, a global patient recruitment and retention company, has just announced GOSH Charity and Oliver Patch Project as their charity partners of the year

Equal Voice in Virtual Meetings – Perks of Virtual Medical Education

Videos and Podcasts | August 1, 2024 | Impetus Digital

In virtual meetings, every participant has the chance to be heard. Our new video from the "Perks of Virtual Medical Education" series explores how features like chat and Q&A ensure...

The importance of being earnest: supporting healthcare professionals in guiding patients through their journey

White Papers and Resources | July 31, 2024 | Mednet

How can clinicians tell patients what they need to understand in a way that is accessible, useful, and actionable?

Empowering patients through more accessible clinical trial information

White Papers and Resources | July 30, 2024 | Cuttsy + Cuttsy

Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...

PLANNING SOCIAL MEDIA CAMPAIGNS – THE HEALTHCARE MARKETER’S GUIDE

White Papers and Resources | July 29, 2024 | IGNIFI

Social media channels are now a key part of how brands and audiences connect and communicate. Audiences are no longer passive recipients to brand messaging; two-way communication is an expectation...